• Radiation Therapy
      • Treatment Delivery
        • Elekta Unity Elekta Unity
        • Versa HD Versa HD
        • Elekta Harmony Elekta Harmony
        • Elekta Infinity Elekta Infinity
        • Elekta Synergy Elekta Synergy
      • Treatment Management
        • Monaco
        • ProKnow
      • Quality Assurance
        • Machine QA
        • Patient QA
    • Stereotactic Radiosurgery
      • Delivery
        • Elekta Esprit Elekta Esprit
        • Leksell Gamma Knife Icon Leksell Gamma Knife Icon
        • Leksell Gamma Knife Perfexion Leksell Gamma Knife Perfexion
        • Versa HD Versa HD
      • Treatment Planning
        • Leksell Gamma Knife Lightning
        • Leksell GammaPlan
    • Oncology Informatics
      • MOSAIQ Plaza
        • Subscribe to Better
        • Professional Services
        • Interoperability
      • Elekta Axis Cloud
    • Brachytherapy
      • Delivery
        • Elekta Studio Elekta Studio
        • ImagingRing ImagingRing
        • Oncentra Brachy Oncentra Brachy
        • Venezia Venezia
        • Flexitron Flexitron
        • Geneva Geneva
      • Body Sites
        • Head and Neck
        • Bronchus and Oesophagus
        • Breast
        • Skin
        • Prostate
        • Rectum
        • Bladder
        • Gynecology
    • Neurosurgery
      • Delivery
        • Leksell Vantage Stereotactic System Leksell Vantage Stereotactic System
        • Leksell Stereotactic System Leksell Stereotactic System
    • Veterinary Radiation Therapy
    • Elekta Care Customer Services
    • Elekta Care 360
    • Elekta Care Learning
    • Elekta Care Community
    • Elekta Partner Community
    • MR-Linac Treatment
    • Brachytherapy Treatment
    • Gamma Knife Treatment
    • Radiation Therapy Treatment
    • Treatment Centers
    • Company
    • Partnering with Elekta
    • About us
      • About us
        • Board of Directors
        • Code of Conduct
        • Corporate Citizenship
        • Executive Management
        • Integrity Line
        • Programs
        • Sponsorship and Donation
        • Story
    • Sustainability
    • Corporate Governance
      • Corporate Governance
        • Shareholders’ meetings
          • Board of Directors
            • Executive Management
              • Auditors
              • Reports
          • Investors
            • Investors
              • Investment case
                • Outlook
                • The share
                  • Financials
                    • Funding
                      • Reports & presentations
                      • Press releases
                      • IR calendar
                      • IR contacts
                  • Newsroom
                    • Newsroom
                      • Press Releases
                      • FOCUS Magazine
                      • Events
                      • Image bank
                  • Careers at Elekta
                    • Jobs
                  • Reimbursement Support & Policy
                ENSV
                Login
                • Products
                  • Radiation Therapy
                    • Treatment Delivery
                      • Elekta Unity
                      • Versa HD
                      • Elekta Harmony
                      • Elekta Infinity
                      • Elekta Synergy
                    • Treatment Management
                      • Monaco
                      • ProKnow
                    • Quality Assurance
                      • Machine QA
                      • Patient QA
                  • Stereotactic Radiosurgery
                    • Delivery
                      • Elekta Esprit
                      • Leksell Gamma Knife Icon
                      • Leksell Gamma Knife Perfexion
                    • Treatment Planning
                      • Leksell Gamma Knife Lightning
                      • Leksell GammaPlan
                    • Versa HD
                  • Oncology Informatics
                    • MOSAIQ Plaza
                      • Subscribe to Better
                      • Professional Services
                      • Interoperability
                    • Elekta Axis Cloud
                  • Brachytherapy
                    • Elekta Studio
                    • ImagingRing
                    • Venezia
                    • Flexitron
                    • Geneva
                    • Head and Neck
                    • Bronchus and Oesophagus
                    • Breast
                    • Skin
                    • Prostate
                    • Rectum
                    • Bladder
                    • Gynecology
                    • Oncentra Brachy
                  • Neurosurgery
                    • Leksell Vantage Stereotactic System
                    • Leksell Stereotactic System
                  • Veterinary Radiation Therapy
                • Services
                  • Elekta Care Customer Services
                  • Elekta Care 360
                  • Elekta Care Learning
                  • Elekta Care Community
                  • Elekta Partner Community
                • Patients
                  • MR-Linac Treatment
                  • Brachytherapy Treatment
                  • Gamma Knife Treatment
                  • Radiation Therapy Treatment
                  • Treatment Centers
                • Company
                  • Partnering with Elekta
                  • About us
                    • Board of Directors
                    • Code of Conduct
                    • Corporate Citizenship
                    • Executive Management
                    • Integrity Line
                    • Programs
                    • Sponsorship and Donation
                    • Story
                  • Sustainability
                  • Corporate Governance
                    • Shareholders’ meetings
                      • Board of Directors
                        • Executive Management
                          • Auditors
                          • Reports
                        • Investors
                          • Investment case
                            • Outlook
                            • The share
                              • Financials
                                • Funding
                                  • Reports & presentations
                                  • Press releases
                                  • IR calendar
                                  • IR contacts
                                • Newsroom
                                  • Press Releases
                                  • FOCUS Magazine
                                  • Events
                                  • Image bank
                                • Careers at Elekta
                                  • Jobs
                                • Reimbursement Support & Policy
                              • Contact
                              • Medical Affairs
                              • Regulatory Affairs
                              • Suppliers
                                • About Elekta Procurement
                                • Sustainable Sourcing
                                • Performance Management
                                  • Production Part Approval Process
                                  • Supplier Escalation Form
                                  • Non Conformance Management
                                  • Supplier Performance Management
                                  • Obsolescence Management
                                • Compliance Management
                                • Invoicing Process
                                • Elekta T&C
                                • Documents & Training
                                • Our Global Presence
                              • Facebook
                              • LinkedIn
                              • Twitter
                              • Instagram
                              • Youtube

                              Remuneration

                              Executive Management

                              • Members
                              • Holdings & transactions
                              • Remuneration

                              Remuneration

                              The guidelines for remuneration to executive management adopted by the annual general meeting 2021 are summarized below. For the complete guidelines, see page 102 in the Annual Report 2020/21.

                              Goal: attract,  motivate and retain competent employees and managers, both in the short and long term.

                              Employment terms for executive management shall include a well-balanced combination of:

                              • Fixed salary
                              • Variable remuneration (annual bonus)
                              • Share-related long-term incentive programs
                              • Special remuneration
                              • Pensions
                              • Other benefits
                              • Termination and severance compensation 

                              The total compensation shall be on market terms on the geographic market where the individual resides or works. As far as possible, remuneration shall be based on performance and thus the annual variable remuneration shall constitute a relatively large portion of the total remuneration.

                              Fixed salary
                              Fixed salary for executive management shall be individual and based on:

                              • Each individual’s responsibilities in relevant position
                              • Individual skills and experience in the relevant position
                              • Regional conditions

                              The fixed salary may amount to between 40 and 50 per cent of the total annual fixed salary and variable remuneration.

                              Variable remuneration (annual bonus)
                              In addition to fixed salary, executive management are entitled to variable remuneration, referred to as an annual bonus. The variable remuneration consists of:

                              • Group’s financial targets: 50-100 per cent of the variable remuneration
                              • Clearly defined individual targets within the respective business area: 0-50 per cent of the variable remuneration

                              Annually to be established by the Board of Directors with the aim of ensuring that they are in line with the Group’s business strategy and long-term interests, including its sustainability, as well as results targets.

                              The size of the variable remuneration varies depending on position and may constitute between 30 and 70 per cent of fixed annual salary at full achievement of targets. There is potential to receive, at most, 200 per cent of the variable remuneration in case of over achievement of targets. Target formulation is structured so that no variable remuneration or bonus is received in the event a minimum performance level or threshold is not achieved.

                              The fulfilment of the targets is concluded through an overall performance assessment. For the President and CEO, and other executive management the Compensation & Sustainability Committee (CSC) is responsible.

                              Elekta may alter, discontinue or cancel parts of the remuneration plan, or the entire plan, and may also subsequently correct the remuneration if an error can be identified.

                              Share-related long-term incentive programs
                              The long-term incentive programs shall align the interests of the shareholders with the interests of executive management and other key individuals at Elekta.

                              As per April 30, 2021, Elekta has three outstanding share programs. A fourth share program was decided upon on Elekta’s AGM 2021. More information is available in Note 7 of the annual report and with respect to the share program for 2021/24, in items 16 a) and 16 b) of the material for the AGM 2021.

                               

                              2017/201)

                              2018/211)

                              2019/222)

                              2020/232)

                              Originally designated number of shares

                              272,379

                              530,799

                              410,307

                              510,622

                              Share price used for calculation of theoretical value SEK

                              82

                              120

                              64

                              65

                              Allotment of shares

                              2020-09-14

                              2021-09-14

                              2022-09-16

                              2023-09-16

                              Number of shares as of April 30, 2020

                              246,958

                              460,164

                              390,702

                              –

                              Number of shares granted during the year

                              –

                              –

                              –

                              510,622

                              Number of shares cancelled/expired during the year

                              –

                              -62,336

                              -75,587

                              -35,775

                              Number of shares released during the year

                              -246,958

                              –

                              –

                              –

                              Number of shares as of April 30, 2021

                              –

                              397,828

                              315,115

                              474,847

                              1)Average closing share price of the Elekta class B share on the exchange NASDAQ Stockholm during a period of ten trading days before the day the participants are offered to participate in the program.
                              2) For the marked-based performance conditions, a Monte Carlo approach has been used to determine the fair value of granted performance shares.

                              More information is available in Note 7 of the annual report and with respect to the share program for 2021/24, in items 16 a) and 16 b) of the material for the AGM 2021.

                              Special remuneration
                              Additional cash variable remuneration can be paid, with a delay in payment up to 36 months, to ensure long-term commitment and that key employees remain in connection with:

                              • Acquisitions of new companies
                              • Divestments of businesses
                              • Other transitional activity
                              • Other extraordinary work endeavours

                              The delayed remuneration may not exceed 50 per cent of the contracted annual fixed remuneration per year. Decisions regarding special remuneration for extraordinary endeavours shall be taken by the Board of Directors.

                              Pensions
                              When new pension agreements are entered into, executive management who are entitled to pension shall only have defined contribution pension agreements. The general rule is that pension provisions are based only on fixed salary and take place at market levels in each country; however, pension provisions shall not exceed 40 per cent of fixed salary.

                              Other benefits
                              Benefits such as company car, compensation for preventive care insurance, healthcare insurance and medical insurance, etc. shall constitute a smaller element of the total compensation package and be in accordance with what is customary on each geographic market. Premiums and other costs for such benefits may not, in total, exceed 20 per cent of fixed salary.

                              Termination terms and severance compensation
                              Termination periods within Elekta shall comply with the statutes and agreements applicable on each geographic market. Termination periods with respect to executive management shall be between 6 and 12 months and, in specific cases, executive management are entitled to severance compensation corresponding to 6-12 months’ fixed salary. In case of certain radical changes in the ownership structure, the President and CEO is entitled to receive additional severance compensation corresponding to 18 months’ fixed salary.

                              Preparation and decision-making procedure

                              Elekta’s CSC shall, each year, prepare remuneration issues and submit to the Board of Directors recommendations. The recommendations shall include:

                              • proposals for structuring bonus systems
                              • the breakdown between fixed and variable remuneration
                              • the size of any salary increases
                              • proposal for criteria for assessment of performance by executive management

                              Decisions regarding remuneration are adopted by the Board of Directors as a whole. The Board of Directors shall prepare proposals for new guidelines at least every fourth year and shall present the proposals for a decision by the AGM.

                              For more information on the composition of CSC, please see Compensation and Sustainability Committee.

                              Derogation from the guidelines

                              The Board of Directors may decide to derogate temporarily from the guidelines, wholly or in part, where there are particular reasons for doing so in an individual case and provided such derogation is necessary to satisfy Elekta’s long-term interests, including its sustainability, or to ensure Elekta’s financial viability.

                              • Products
                                • Radiation Therapy
                                • Stereotactic Radiosurgery
                                • Oncology Informatics
                                • Brachytherapy
                                • Neurosurgery
                                • Veterinary Radiation Therapy
                              • Services
                                • Elekta Care Customer Services
                                • Elekta Care 360
                                • Elekta Care Learning
                                • Elekta Care Community
                                • Elekta Partner Community
                              • Patients
                                • MR-Linac Treatment
                                • Brachytherapy Treatment
                                • Gamma Knife Treatment
                                • Radiation Therapy Treatment
                                • Treatment Centers
                              • Company
                                • Partnering with Elekta
                                • About us
                                • Sustainability
                                • Corporate Governance
                                • Investors
                                • Newsroom
                                • Careers at Elekta
                                • Country and regional pages
                                • Digital Product Security
                                • Offices
                              • Facebook
                              • LinkedIn
                              • Twitter
                              • Instagram
                              • Youtube
                              • ©2023 Elekta
                              • Legal notices
                              • Privacy policy
                              • Cookies
                              • Subscription center

                              Important Safety Information: Radiation therapy is not appropriate for all patients. Radiation treatments may cause side effects that can vary depending on the part of the body being treated. In some patients, they can be severe. Treatment sessions may vary in complexity and time. Refer to individual product labeling (instructions for use) for more complete information on product safety and effectiveness for its intended use.

                              Contact and Support

                              Offices Customer support
                              Please note: due to bot protection, submitting a non-work email may result in longer reponse times.

                              By clicking the 'Submit' button below you agree to the Elekta Privacy Policy.

                              © 2023 Elekta

                              • Legal notices
                              • Privacy policy
                              • Cookies
                              • Subscription center

                              Important Safety Information: Radiation therapy is not appropriate for all patients. Radiation treatments may cause side effects that can vary depending on the part of the body being treated. In some patients, they can be severe. Treatment sessions may vary in complexity and time. Refer to individual product labeling (instructions for use) for more complete information on product safety and effectiveness for its intended use.